Psilera Selects bvFTD as Lead Indication for Clinical Testing of Psychedelic Derivative

January 25, 2024

Compass Pathways Forges Research Collaboration with Hackensack Meridian Health

January 19, 2024

Optimi Health Obtains Permit to Increase MDMA Production

January 19, 2024

Johns Hopkins Professor Matthew Johnson Joins Sheppard Pratt’s Psilocybin Research Center

January 19, 2024

What Is Ibogaine?

January 16, 2024

Usona Researchers Discover New Compounds With Psychedelic Properties

January 14, 2024